2-(7-Chloro-5-phenyl-[1,2,4]triazolo[4,3-a]quinolin-1-yl)-N,N-dimethylethan-1-amine, 98%, 100mg

D-Aspartic Acid>98.0%(HPLC)(T)25g

4-Bromo-2-methylthiophene, 95.0%, 500g

(2-Chlorophenyl)acetic acid ethyl ester, 95.0%, 10g

Hexacianoferrato(II) de potasio trihidrato, mínimo 98,5 %, cristalizado, 250 g, envase de plástico.

6-BROMO-2-CHLORO-5-FLUORO-QUINAZOLINE, 95.0%, 1g

[(1R)-1-phenylethyl](propan-2-yl)amine, 95.0%, 2.5g

2,6-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[1,2-b:4,5-b']dithiophene>97.0%(GC)5g

Methyl benzo[d]thiazole-4-carboxylate, 97.0%, 1g

4-Bromo-1,2-bis(bromomethyl)benzene, 95.0%, 250mg

Fmoc-D-Ser-OH, 95%, 5g

(R)-3-Hydroxypiperidine hydrochloride, 98.0%, 25g

5-Bromo-7-nitroindoline, 98.0%, 250mg